Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
A
A

AstraZeneca

Balita

Reuters - 14 oras ang nakaraan

US natgas prices drop 7% to 10-week low on Texas Freeport LNG outage

UPDATE 1-US natgas prices drop 7% to 10-week low on Texas Freeport LNG outage Adds latest prices By Scott DiSavino July 15 (Reuters) - U.S. natural gas futures fell about 7% to a 10-week low on Monday due to the slow return of the Freeport LNG export plant in Texas after shutting for Hurricane Beryl and on forecasts for less hot weather and lower demand over the next two weeks than previously expected Freeport said it is repairing damage sustained in the hurricane.
A
N
Reuters - 19 oras ang nakaraan

US natgas prices fall 4% to 9-week low on forecasts for less heat, demand

US natgas prices fall 4% to 9-week low on forecasts for less heat, demand By Scott DiSavino July 15 (Reuters) - U.S. natural gas futures fell about 4% to a nine-week low on Monday on forecasts for less hot weather and lower demand over the next two weeks than previously expected. Traders also noted prices were depressed by rising output, the tremendous oversupply of gas still in storage and the slow return of the Freeport LNG export plant in Texas after shutting ahead of Hurricane Beryl.
A
N
Reuters - 1 araw ang nakaraan

Astrazeneca Closes Acquisition Of Amolyt Pharma

BRIEF-Astrazeneca Closes Acquisition Of Amolyt Pharma July 15 (Reuters) - Amolyt Pharma: ASTRAZENECA CLOSES ACQUISITION OF AMOLYT PHARMA Source text for Eikon: ID:nGNX72s32L Further company coverage: AZN.L
A
Reuters - 4 araw ang nakaraan

US natgas prices settle up over 2% on hot-weather forecasts

UPDATE 1-US natgas prices settle up over 2% on hot-weather forecasts Updates prices and market activity to settlement July 12 (Reuters) - U.S. natural gas futures rose more than 2% on Friday after touching their lowest in close to two-months during in the session, boosted by forecasts for hotter weather over the next two weeks that should boost air-conditioning demand.
A
Reuters - 4 araw ang nakaraan

US natgas prices rise more than 2% on hot-weather forecasts

US natgas prices rise more than 2% on hot-weather forecasts July 12 (Reuters) - U.S. natural gas futures rose more than 2% on Friday after touching their lowest in close to two-months earlier in the session, helped by forecasts for warmer than usual weather over the next two weeks than previously expected. Warmer than normal weather triggers air conditioning demand.
A
Reuters - 4 araw ang nakaraan

EMA's PRAC Says Could Not Establish A Causal Association Between 1 Analogues And Aspiration

BRIEF-EMA's PRAC Says Could Not Establish A Causal Association Between GLP-1 Analogues And Aspiration July 12 (Reuters) - EMA's PRAC: EMA'S PRAC: NEW RECOMMENDATIONS FOR GLP-1 RECEPTOR AGONISTS TO MINIMISE RISK OF ASPIRATION & PNEUMONIA ASPIRATION IN GENERAL ANAESTHESIA/DEEP SEDATION EMA'S PRAC: PATIENTS TREATED WITH GLP-1 MEDICINES SHOULD INFORM T
A
S
Reuters - 5 araw ang nakaraan

US natgas prices fall 3% to two-month low on big storage build, rising output

UPDATE 1-US natgas prices fall 3% to two-month low on big storage build, rising output Adds closing prices By Scott DiSavino July 11 (Reuters) - U.S. natural gas futures fell about 3% to a two-month low on Thursday on a bigger-than-expected weekly storage build as output rose and the amount of gas flowing to liquefied natural gas (LNG) export plants dropped after Freeport LNG in Texas shut early this week for Hurricane Beryl.
A
Reuters - 5 araw ang nakaraan

US natgas prices fall 2% to two-month low on big storage build, rising output

US natgas prices fall 2% to two-month low on big storage build, rising output By Scott DiSavino July 11 (Reuters) - U.S. natural gas futures fell about 2% to a two-month low on Thursday on a bigger-than-expected weekly storage build as output rose and the amount of gas flowing to liquefied natural gas (LNG) export plants dropped after Freeport LNG in Texas shut early this week for Hurricane Beryl.
A
Reuters - 5 araw ang nakaraan

Diageo, Publicis, Wolters Kluwer NV

EUROPE RESEARCH ROUNDUP-Diageo, Publicis, Wolters Kluwer NV July 11 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Diageo, Publicis and Wolters Kluwer NV, on Thursday. HIGHLIGHTS * Diageo DGE.L : HSBC cuts target price to 3,300p from 3,500p * Mfe-Mediaforeurope NV MFEB.MI : JP Morgan raises to overweight from neutral * Prosiebensat 1 Media SE PSMGn.DE : JP Morgan raises to overweight from neutral * Publicis PUBP.PA : JP Morgan cuts
A
A
A
B
C
C
D
D
D
D
E
E
G
H
K
L
P
R
S
S
V
A
A
A
A
B
D
G
J
W
Reuters - 6 araw ang nakaraan

US natgas prices ease on rising output, lower LNG feedgas

UPDATE 1-US natgas prices ease on rising output, lower LNG feedgas Adds latest prices By Scott DiSavino July 10 (Reuters) - U.S. natural gas futures eased about 1% on Wednesday on recent increases in output, a drop in the amount of gas flowing to liquefied natural gas (LNG) export plants after Freeport LNG in Texas shut for Hurricane Beryl and a tremendous surplus of gas in storage for this time of year.
A
Reuters - 6 araw ang nakaraan

US natgas prices ease on rising output, lower LNG feedgas

US natgas prices ease on rising output, lower LNG feedgas By Scott DiSavino July 10 (Reuters) - U.S. natural gas futures eased about 1% on Wednesday on recent increases in output, a drop in the amount of gas flowing to liquefied natural gas (LNG) export plants after Freeport LNG in Texas shut for Hurricane Beryl and a tremendous surplus of gas in storage for this time of year.
A
Reuters - 6 araw ang nakaraan

Danske Bank, Entain, Halma

EUROPE RESEARCH ROUNDUP-Danske Bank, Entain, Halma July 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Danske Bank, Entain and Halma, on Wednesday. HIGHLIGHTS * Danske Bank DANSKE.CO : Berenberg initiates coverage with hold rating; PT DKK 215 * Entain ENT.L : JP Morgan cuts target price to 900p from 910p * Halma HLMA.L : JP Morgan raises target price to 2,350p from 2,000p * Novonesis NSISb.CO : JP Morgan raises target price to
A
A
A
B
B
C
C
C
D
E
E
E
H
L
P
P
S
S
S
S
V
A
A
A
A
A
A
B
J
Reuters - 1 linggo ang nakaraan

US natgas prices ease on forecasts for less demand next week, lower LNG feedgas

UPDATE 1-US natgas prices ease on forecasts for less demand next week, lower LNG feedgas Adds closing prices By Scott DiSavino July 9 (Reuters) - U.S. natural gas futures eased about 1% on Tuesday on forecasts for less demand next week than previously expected, recent increases in output and a drop in the amount of gas flowing to liquefied natural gas (LNG) export plants after Freeport LNG in Texas shut for Hurricane Beryl.
A
N
Reuters - 1 linggo ang nakaraan

US natgas prices rise 3% as heat wave boosts power demand for gas

US natgas prices rise 3% as heat wave boosts power demand for gas By Scott DiSavino July 9 (Reuters) - U.S. natural gas futures climbed about 3% on Tuesday on forecasts for the brutal heat wave blanketing much of the country to remain in place through at least late July, forcing power generators to burn lots of gas to produce electricity to keep air conditioners humming.
A
N
Reuters - 1 linggo ang nakaraan

US natgas prices climb 2% on forecasts for more demand in heat wave

UPDATE 1-US natgas prices climb 2% on forecasts for more demand in heat wave Adds closing prices By Scott DiSavino July 8 (Reuters) - U.S. natural gas futures climbed about 2% on Monday on forecasts for more demand next week than previously expected as a brutal heat wave continues to blanket much of the country, forcing power generators to burn more gas to produce electricity to keep air conditioners humming.
A
N
Reuters - 1 linggo ang nakaraan

US natgas prices climb 2% on forecasts for more demand

US natgas prices climb 2% on forecasts for more demand By Scott DiSavino July 8 (Reuters) - U.S. natural gas futures climbed about 2% on Monday on forecasts for more demand next week than previously expected as a brutal heat wave continues to blanket much of the country, forcing power generators to burn more gas to produce electricity to keep air conditioners humming.
A
N
Reuters - 2 linggo ang nakaraan

US natural gas prices drop to 7-week low on rising output, high storage levels

UPDATE 1-US natural gas prices drop to 7-week low on rising output, high storage levels Adds latest prices July 5 (Reuters) - U.S. natural gas futures slipped over 4% to a seven-week low on Friday, as rising output and ample gas supply in storage outweighed support from forecasts for higher demand over the next two weeks. Front-month gas futures NGc1 for August delivery on the New York Mercantile Exchange fell 9.5 cents , to settle at $2.31 9 per million British thermal units (mmBtu).
A
Reuters - 2 linggo ang nakaraan

US natural gas prices drop to 7-week low on rising output, high storage levels

US natural gas prices drop to 7-week low on rising output, high storage levels July 5 (Reuters) - U.S. natural gas futures slipped nearly 2% to a seven-week low on Friday, as rising output and ample gas supply in storage outweighed support from forecasts for higher demand over the next two weeks. Front-month gas futures NGc1 for May delivery on the New York Mercantile Exchange were down 4.6 cents, or 1.9%, to $2.37 per million British thermal units (mmBtu) at 10:57 a.m.
A
N
Reuters - 2 linggo ang nakaraan

Anti-TIGIT drugmakers down as Roche's lung cancer drug fails trial

BUZZ-Anti-TIGIT drugmakers down as Roche's lung cancer drug fails trial Updates ** U.S.-listed shares of Israel-based therapy developer Compugen CGEN.TA fall ~3% to $1.62 premarket ** Switzerland-based Roche's ROG.S drug tiragolumab, which is part of a new class of drugs known as anti-TIGIT, failed a lung cancer treatment trial on Thursday ** CGEN
A
R
Reuters - 2 linggo ang nakaraan

Compugen down as Roche's 'anti-TIGIT' lung cancer drug fails trial

BUZZ-Compugen down as Roche's 'anti-TIGIT' lung cancer drug fails trial ** U.S.-listed shares of Israel-based therapy developer Compugen CGEN.TA fall ~3% to $1.62 premarket ** Switzerland-based Roche's ROG.S drug tiragolumab, which is part of a new class of drugs known as anti-TIGIT, failed a lung cancer treatment trial on Thursday ** CGEN has colo
A
R

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.